Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.

De Santis E, Di Vito M, Perrone GA, Mari E, Osti M, De Antoni E, Coppola L, Tafani M, Carpi A, Russo MA.

Biomed Pharmacother. 2013 Feb;67(1):7-16. doi: 10.1016/j.biopha.2012.08.003. Epub 2012 Sep 16.

PMID:
23089475
2.

Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.

Di Vito M, De Santis E, Perrone GA, Mari E, Giordano MC, De Antoni E, Coppola L, Fadda G, Tafani M, Carpi A, Russo MA.

Cancer Sci. 2011 Oct;102(10):1921-7. doi: 10.1111/j.1349-7006.2011.02017.x. Epub 2011 Jul 27.

3.

Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment.

Tafani M, Russo A, Di Vito M, Sale P, Pellegrini L, Schito L, Gentileschi S, Bracaglia R, Marandino F, Garaci E, Russo MA.

Cancer Sci. 2010 Apr;101(4):1014-23. doi: 10.1111/j.1349-7006.2010.01493.x. Epub 2010 Jan 12.

4.

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.

Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, Raco A, Salvati M, De Maria R, Russo MA.

J Neuroinflammation. 2011 Apr 13;8:32. doi: 10.1186/1742-2094-8-32.

5.

Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression.

Tafani M, De Santis E, Coppola L, Perrone GA, Carnevale I, Russo A, Pucci B, Carpi A, Bizzarri M, Russo MA.

Biomed Pharmacother. 2014 Feb;68(1):1-5. doi: 10.1016/j.biopha.2013.10.013. Epub 2013 Nov 15. Review.

PMID:
24286852
6.

LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.

Zhao S, Wang Q, Li Z, Ma X, Wu L, Ji H, Qin G.

J Exp Clin Cancer Res. 2015 Dec 4;34:146. doi: 10.1186/s13046-015-0265-z.

7.

Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.

Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, He F, Moore FD Jr, Clark OH, Ruan DT.

J Clin Endocrinol Metab. 2011 Mar;96(3):E554-65. doi: 10.1210/jc.2010-1800. Epub 2010 Dec 29.

PMID:
21190978
8.

Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.

Burrows N, Resch J, Cowen RL, von Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G.

Endocr Relat Cancer. 2010 Jan 29;17(1):61-72. doi: 10.1677/ERC-08-0251. Print 2010 Mar.

9.

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Ma Y, Qin H, Cui Y.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):958-63. doi: 10.1016/j.bbrc.2013.11.010. Epub 2013 Nov 9.

PMID:
24220341
10.

Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.

Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.

Urol Int. 2012;88(1):95-101. doi: 10.1159/000331881. Epub 2011 Oct 25.

PMID:
22041818
11.

Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.

Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R, Fahey TJ 3rd.

Surgery. 2014 Dec;156(6):1342-50; discussion 1350. doi: 10.1016/j.surg.2014.08.007. Epub 2014 Nov 11.

PMID:
25456905
13.

PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Jendrzejewski J, Thomas A, Liyanarachchi S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak K, de la Chapelle A.

J Clin Endocrinol Metab. 2015 Oct;100(10):E1370-7. doi: 10.1210/jc.2015-2247. Epub 2015 Aug 14.

14.

SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.

Moraitis D, Karanikou M, Liakou C, Dimas K, Tzimas G, Tseleni-Balafouta S, Patsouris E, Rassidakis GZ, Kouvaraki MA.

Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.

PMID:
25456951
15.

Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.

Zhang H, Teng X, Liu Z, Zhang L, Liu Z.

J Exp Clin Cancer Res. 2015 Feb 12;34:16. doi: 10.1186/s13046-015-0132-y.

16.

MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.

Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z.

Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.

17.

In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF (V600E) mutation status and together with hypoxia-related proteins predicts aggressive behavior.

Ilie MI, Lassalle S, Long-Mira E, Hofman V, Zangari J, Bénaim G, Bozec A, Guevara N, Haudebourg J, Birtwisle-Peyrottes I, Santini J, Brest P, Hofman P.

Virchows Arch. 2013 Sep;463(3):437-44. doi: 10.1007/s00428-013-1453-x. Epub 2013 Jul 27.

PMID:
23893334
18.

Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.

Bai H, Ge S, Lu J, Qian G, Xu R.

J Obstet Gynaecol Res. 2013 Feb;39(2):555-63. doi: 10.1111/j.1447-0756.2012.01995.x. Epub 2012 Aug 26.

PMID:
22925504
19.

Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.

Shen H, Yang Y, Xia S, Rao B, Zhang J, Wang J.

Dis Esophagus. 2014 Sep-Oct;27(7):685-92. doi: 10.1111/dote.12124. Epub 2013 Sep 13.

PMID:
24028437
20.

The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, de la Chapelle A.

Proc Natl Acad Sci U S A. 2012 May 29;109(22):8646-51. doi: 10.1073/pnas.1205654109. Epub 2012 May 14.

Supplemental Content

Support Center